LEENA JOHN: Open Payments
NPI 1811254907 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,801 in 69 payments from 19 companies in 2025. Trend: 2023 $903 · 2024 $1,341 · 2025 $1,801
Food & beverage: $1,802
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 13 | $265 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $202 |
| UROGEN PHARMA, INC. | 1 | $170 |
| Verity Pharmaceuticals Inc. | 10 | $168 |
| ABBVIE INC. | 8 | $152 |
| Endo USA, Inc. | 5 | $140 |
| TOLMAR, INC. | 4 | $116 |
| Astellas Pharma US Inc | 4 | $113 |
| Janssen Biotech, Inc. | 3 | $97 |
| Medtronic, Inc. | 1 | $72 |
Products named: Nubeqa, JELMYTO, GEMTESA, AVEED, Xtandi, LUPRON DEPOT, ORGOVYX, ERLEADA.
Industry payments across GA — which companies pay providers there.
